How Torigen Works

home_banner.jpg

Our Process

 
hiw-step1.jpg
 
 

STEP 1

Veterinarians surgically excise the tumor and ship it to our lab for processing.

 
 

STEP 2

Our lab will prepare a personalized vaccine from the tumor, which will be sent back to your vet clinic.

 
 
step_2.jpg
 
hiw-step3.png
 
 

STEP 3

Veterinarians administer the personalized vaccine by injection once a week for three weeks.

 
 

HARNESSING THE IMMUNE SYSTEM TO FIGHT CANCER

Are you interested in offering our cancer treatment for the animals in your care?

 

The Science of Tissue Vaccines

Torigen has 10+ years of supporting pre-clinical research behind our treatment, a whole cell tissue vaccine. Because this therapy is produced directly from harvested tumor material, it avoids distortion of the antigenic menu that can result from in vitro culture. This allows for a variety of tumor-associated antigens to be presented to the immune system, which may increase the likelihood of a successful response.


So far, more than 1,200 companion animals have been treated with our autologous prescription product.

science-of-tissue.jpg
 
Immunotherapy.jpg
 

Immunotherapy For Your Practice

Torigen offers an autologous prescription product for dogs, cats and horses that uses the animal’s own tumor cells to create a personalized immunotherapy. It comes with a simple protocol, and can be used alone or in combination with chemotherapy and radiation. Now, you can offer a cancer treatment at an affordable price, all within your practice.

 

Torigen Can Help You Make a Difference

Our treatment is a whole cell tissue vaccine, which works by generating specific adaptive immunity to tumor associated antigens found on the outside surface of tumor cells.

Broad Spectrum

Contains a variety of antigen targets for the immune system.

Diverse Applications

Includes the necessary components to potentiate an immune response against multiple cancer types.

Affordable

Considerably less expensive when compared to other available cancer treatment options.

 

Immunotherapy Preparation

In order to create the vaccine for your patient, the tumor must meet the following criteria:

Tumor must be surgically excised or biopsied in order to provide a minimum of 2-5 grams (1-5 cubic centimeters) of non-necrotic tissue.


It can not be fixed in formalin.

Veterinarians have frequently treated the following cancers with the Torigen Autologous Cancer Vaccine:
  • Anal Sac Adenocarcinoma
  • Hemangiosarcoma
  • Fibrosarcoma
  • Mast Cell Tumors
  • Melanoma
  • Soft Tissue Sarcoma
  • Hepatocellular Carcinoma
  • Nasal Carcinoma
  • Squamous Cell Carcinoma
  • Transitional Cell Carcinoma

Torigen can also provide pathology services through our 3rd party reference labs (Vidium, Specialty Vet Path, IDEXX, Antech, Zoetis, VDx, VetPath - New York, SOPA ) if there is a sufficient quantity of tissue available. If you have requested pathology, and there is insufficient tumor tissue, our priority will be on getting the histologic diagnosis to allow for best patient care. The tumor tissue must be submitted to us fresh, non-formalin fixed.

Torigen is able to create the individualized immunotherapy from most solid tumors. For lymphoma and osteosarcoma, please call before submission to discuss the use of concurrent therapy, or waiting until the patient is in clinical remission before proceeding with immunotherapy.